September 28-29, 2026 | The Lighthouse, Chelsea Piers, New York City

7th Bioelectronic Medicine Summit

Bioelectronic Medicine (BEM) combines molecular medicine, neuroscience, and biomedical engineering to treat disease with device-based therapies. The BEM Summit is an international meeting that brings together leaders across academia, medicine, and industry to discuss recent developments and in-progress work that will inform the future of the field. In 2026, we have the 7th BEM Summit focused on New Targets and Therapies Across Organs and Systems.

Register Here

New Targets and Therapies Across Organs and Systems

The rapidly advancing field of Bioelectronic Medicine (BEM) combines a variety of disciplines to develop device-based therapies for treating human disease. With BEM therapies recently approved for clinical use, and several others advancing through late-phase clinical trials, the field stands at an inflection point where decades of basic science research are translating into transformative therapies spanning multiple organ systems. The 7th BEM Summit will highlight the latest work across academic labs, BEM-relevant companies, and clinical advances that will inform the next generation of therapies in the field.

Featured sessions include:

Nerve Pathways and Tools in the Heart and Airways
Nerve Pathways and Tools in the Liver and Gut
Ultrasound Tools for the Brain Targets
Brain Computer Interfaces to Improve Human Health
New Technology Development in Bioelectronics
Neuroimmune Modulation and Translation
Neuromodulation to Treat Cancer
Technology and Disease-specific Foundation Panel
Clinical Translation of Devices to Treat Disease

Preliminary Agenda is now available!

2026 Featured Speakers

Edward S. Boyden, PhD

Professor, MIT Media Lab & McGovern Institute, HHMI, Massachusetts Institute of Technology (MIT)

Mikhail G. Shapiro, PhD

Max Delbrück Professor of Chemical Engineering & Medical Engineering, HHMI, California Institute of Technology (Caltech)

Hong Chen, PhD

Professor, Department of Biomedical Engineering, Washington University in St. Louis

Stephen D. Liberles, PhD

Professor, Department of Cell Biology; HHMI Investigator, Harvard Medical School

Molly Stevens, PhD

Professor Dame, Institute of Biomedical Engineering, Deputy Director, Kavli Institute for Nanoscience Discovery; University of Oxford